losartan has been researched along with Atheroma in 5 studies
Losartan: An antagonist of ANGIOTENSIN TYPE 1 RECEPTOR with antihypertensive activity due to the reduced pressor effect of ANGIOTENSIN II.
losartan : A biphenylyltetrazole where a 1,1'-biphenyl group is attached at the 5-position and has an additional trisubstituted imidazol-1-ylmethyl group at the 4'-position
| Excerpt | Relevance | Reference |
|---|---|---|
| "To investigate whether the combination of fluvastatin and losartan synergistically relieve atherosclerosis and plaque inflammation induced by a high-cholesterol diet in rabbits." | 7.77 | Combination of fluvastatin and losartan relieves atherosclerosis and macrophage infiltration in atherosclerotic plaques in rabbits. ( Dong, B; Dong, QL; Jiang, H; Li, SY; Liu, CX; Liu, XX; Liu, ZZ; Wang, N; Xu, H; Yang, YP; Zhang, XH; Zhang, YH; Zhu, L, 2011) |
| "The anti-atherosclerosis effects of Ang-(1-7) and losartan in early lesion formation were equivalent." | 3.81 | Comparison of angiotensin-(1-7), losartan and their combination on atherosclerotic plaque formation in apolipoprotein E knockout mice. ( Dong, M; Guan, J; Meng, X; Niu, R; Sun, Y; Yang, J; Yang, X; Zhang, C; Zhang, Y, 2015) |
| "To investigate whether the combination of fluvastatin and losartan synergistically relieve atherosclerosis and plaque inflammation induced by a high-cholesterol diet in rabbits." | 3.77 | Combination of fluvastatin and losartan relieves atherosclerosis and macrophage infiltration in atherosclerotic plaques in rabbits. ( Dong, B; Dong, QL; Jiang, H; Li, SY; Liu, CX; Liu, XX; Liu, ZZ; Wang, N; Xu, H; Yang, YP; Zhang, XH; Zhang, YH; Zhu, L, 2011) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 5 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Shu, S | 1 |
| Zhang, Y | 2 |
| Li, W | 1 |
| Wang, L | 1 |
| Wu, Y | 1 |
| Yuan, Z | 1 |
| Zhou, J | 1 |
| Zhang, YH | 2 |
| Hao, QQ | 1 |
| Wang, XY | 1 |
| Chen, X | 1 |
| Wang, N | 2 |
| Zhu, L | 2 |
| Li, SY | 2 |
| Yu, QT | 1 |
| Dong, B | 2 |
| Yang, J | 1 |
| Sun, Y | 1 |
| Dong, M | 1 |
| Yang, X | 1 |
| Meng, X | 1 |
| Niu, R | 1 |
| Guan, J | 1 |
| Zhang, C | 1 |
| Yang, YP | 1 |
| Dong, QL | 1 |
| Zhang, XH | 1 |
| Liu, ZZ | 1 |
| Xu, H | 1 |
| Jiang, H | 1 |
| Liu, CX | 1 |
| Liu, XX | 1 |
| Van Eeden, S | 1 |
| Leipsic, J | 1 |
| Paul Man, SF | 1 |
| Sin, DD | 1 |
1 review available for losartan and Atheroma
| Article | Year |
|---|---|
The relationship between lung inflammation and cardiovascular disease.
Topics: Adrenergic beta-Antagonists; Angiotensin II Type 1 Receptor Blockers; Animals; Cardiovascular Diseas | 2012 |
4 other studies available for losartan and Atheroma
| Article | Year |
|---|---|
The role of monocyte chemotactic protein-induced protein 1 (MCPIP1) in angiotensin II-induced macrophage apoptosis and vulnerable plaque formation.
Topics: AMP-Activated Protein Kinases; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Apo | 2019 |
ACE2 activity was increased in atherosclerotic plaque by losartan: Possible relation to anti-atherosclerosis.
Topics: Angiotensin I; Angiotensin-Converting Enzyme 2; Animals; Down-Regulation; Extracellular Signal-Regul | 2015 |
Comparison of angiotensin-(1-7), losartan and their combination on atherosclerotic plaque formation in apolipoprotein E knockout mice.
Topics: Angiotensin I; Angiotensin II Type 1 Receptor Blockers; Animals; Aorta, Abdominal; Aortic Diseases; | 2015 |
Combination of fluvastatin and losartan relieves atherosclerosis and macrophage infiltration in atherosclerotic plaques in rabbits.
Topics: Animals; Atherosclerosis; Chemokine CCL2; Cholesterol; Drug Synergism; Fatty Acids, Monounsaturated; | 2011 |